0.15Open0.15Pre Close0 Volume971 Open Interest88.00Strike Price0.00Turnover82.90%IV15.36%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.0555Delta0.0170Gamma509.40Leverage Ratio-0.0823Theta0.0004Rho28.26Eff Leverage0.0089Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet